OxyPrem
PrivateLast Round
Crowdfunding
Feb 28, 2025
Est. Valuation
$22.6M
Total Funding Raised
$5.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OxyPrem operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Crowdfunding round in February 2025.
OxyPrem is a healthtech company that develops a medical silicon device to measure brain oxygen levels of preterm infants.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OxyPrem Comparables
Compare OxyPrem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medtronic | 74% | |
| Nonin Medical | 73% | |
| Danaher Corporation | 72% |
For institutional investors. Book with your work email.
OxyPrem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Feb 28, 2025 | ||||
| Grant | Jan 1, 2022 | ||||
| Grant | Aug 7, 2020 | ||||
| Accelerator | Aug 2, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OxyPrem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
| Wyss Zurich | Accelerator |
| MassChallenge Israel | Accelerator |
| Venture Kick | Accelerator |
| Capital Cell | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 18% QoQ from 17 to 20 employees.
- Apr 20, 2026
Monthly visitors grew 3322% MoM, from 9 to 308.
For institutional investors. Book with your work email.
OxyPrem Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OxyPrem's valuation, stock price, and market status.
Is OxyPrem a public or private company?
OxyPrem is a private company.
What is the current stock price of OxyPrem?
OxyPrem is a private company, so its shares have no public market price. Caplight tracks OxyPrem's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OxyPrem worth (valuation)?
OxyPrem's valuation is estimated at $22.6M based on funding round data.
Can I buy OxyPrem stock?
OxyPrem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OxyPrem's last funding round?
OxyPrem's most recent funding round was Crowdfunding on February 28, 2025.
Who are the main investors in OxyPrem?
Key investors in OxyPrem include Venture Kick.
Will OxyPrem IPO soon?
No public IPO plans have been announced for OxyPrem.
How can I track OxyPrem secondary market activity?
Caplight tracks bids, offers, and trades in OxyPrem's shares on secondary markets.